Crohn's disease Trials in Rostov-on-Don, Russia
Conditions / Crohn's disease / Rostov-on-Don, Russia
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01316939 | GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT03466411 | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT04232553 | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01536418 | An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT01318993 | Open-Label Extension Study of GSK1605786A | TERMINATED | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT02641392 | A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT02620046 | A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease | COMPLETED | PHASE3 |
| NCT03926130 | A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | COMPLETED | PHASE3 |
| NCT03627091 | Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) | TERMINATED | PHASE3 |